Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

07 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2016 Thomson Reuters Stock Report 11 $25.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceut...

18 May 2016 GlobalData 55 $300.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

08 May 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 May 2016 Wright Reports 55 $75.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceut...

28 Mar 2016 GlobalData 58 $300.00

Company Snapshot - Aurobindo Pharma Limited

A director at Aurobindo Pharma Limited bought 4,800 shares at 0.000INR and the significance rating of the trade was 54/100. ...

02 Mar 2016 Directors Deals Ltd. 1 $12.00

MOSL: Aurobindo Pharma 3QFY16 (Buy)-In line result-FCF generation bodes well

AUROBINDO PHARMA 3QFY16: In line result; FCF generation bodes well (ARBP IN, Mkt Cap USD6b, CMP INR692, TP INR1100, 59% Upsi...

11 Feb 2016 Motilal Oswal Securities Ltd. 12 $115.00

Aurobindo Pharma_Q3FY16 Result Update

Aurobindo Pharma Considerable sales growth yet to kick in US market post ANDA approvals Aurobindo Pharma’s (ARBP) financi...

11 Feb 2016 IndiaNivesh Securities Pvt Ltd 5 $46.00

Spark Capital: Aurobindo Pharma 3QFY16 Outlook Review (TP: Rs. 1015; Rating: BUY)

Aurobindo Pharma 3QFY16 Outlook Review (TP: Rs. 1015; Rating: BUY) How does our one year outlook change? We maintain BU...

11 Feb 2016 Spark Capital Advisors(India) Private Limited 5 $35.00